Estimated Cost-effectiveness of Subcutaneous Insulin Aspart in the Management of Mild Diabetic Ketoacidosis Among Children

IMPORTANCE: Intravenous (IV) insulin infusion is the standard of care for treating diabetic ketoacidosis (DKA) worldwide. Subcutaneous (SC) insulin aspart could decrease the use of health care resources. OBJECTIVE: To compare the cost-effectiveness of mild uncomplicated DKA management with SC insuli...

Descripción completa

Detalles Bibliográficos
Autores principales: Bali, Ibrahim Abdulaziz, Al-Jelaify, Muneera Rashid, AlRuthia, Yazed, Mulla, Jaazeel Zohair, Amlih, Dana Fawzi, Bin Omair, Alanoud Ibrahim, Al Khalifah, Reem Abdullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449786/
https://www.ncbi.nlm.nih.gov/pubmed/36066894
http://dx.doi.org/10.1001/jamanetworkopen.2022.30043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449786/
https://www.ncbi.nlm.nih.gov/pubmed/36066894
http://dx.doi.org/10.1001/jamanetworkopen.2022.30043

Ejemplares similares